A new Transparency Market Research report states that the global apheresis equipment market stood at US$1.1 bn in 2011 and is predicted to reach US$2.3 bn in 2018. It is predicted to expand at a CAGR of 11.30% from 2012 to 2018. The title of the report is “Apheresis Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018.”
Apheresis is a type of medical technology wherein the blood of a patient or donor is passed via an apparatus separating out one specific constituent and returning the remainder to the donor’s body. It is therefore called as extracorporeal therapy. An apheresis equipment is a device that which receives the blood of a donor or patient and separates the blood into its numerous components such as white blood cells, plasma, platelets, and red blood cells. By using apheresis, abnormal cells or substances in the blood of patients can be removed, resulting in control or cure of a particular disease.
Read Full Report: http://www.transparencymarketresearch.com/apheresis-equipment.html
As per the report, the market for apheresis equipment is fuelled by the rising count of platelet donors, advancement in the healthcare infrastructure in developing economies, rising demand for plasma, and the favorable policies of reimbursement. The prime growth opportunity in the market is the growing application of therapeutic apheresis in anti-aging procedures. On the other hand, risks related to the adoption of apheresis, soaring prices of equipment, the absence of skilled professionals, and lowering count of donors are amongst the chief factors that may restrain the growth of the market in the coming years.
On the basis of technology, the apheresis equipment market is segmented into membrane filtration and centrifugation. In terms of procedure, the report segments the apheresis equipment market into plasmapheresis, LDL-apheresis, photopheresis, leukapheresis, plateletpheresis, erythrocytapheresis, and others. On the basis of application, the market is segmented into neurology, renal diseases, hematology, and others.
In terms of geography, the report segments the market into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, in 2012, Europe and North America collectively accounted for a share of more than 50% in the market for apheresis equipment. This is owing to the advanced and sophisticated healthcare facilities within these regions and the improvement of medical devices in these two regions. Europe and North America have also excelled in research and development and thus have emerged as prime centers for the manufacturers operating in the market for apheresis equipment.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=871
According to the report, the major players operating in the global apheresis equipment market are Fresenius Medical Care (Germany), Haemonetics Corporation (U.S.), Terumo BCT, Inc. (U.S.), Kawasumi Laboratories Inc. (Japan), Asahi Kasei Medical Co., Ltd. (Japan), Cerus Corporation (U.S.), HemaCare Corporation (U.S.), B. Braun Melsungen AG (Germany), Medica S.p.A. (Italy), Nikkiso Co., Ltd. (Japan) , Kaneka Corporation (Japan), and Therakos, Inc. (U.S.), among others.
The global apheresis equipment market is segmented as follows:
- Apheresis equipment market, by types of applications
- Renal diseases
- Apheresis equipment market, by types of procedures
- Apheresis machines market, by technology
- Membrane filtration
- Apheresis equipment market, by geography
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453